DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Niaspan (Niacin Extended-Release) - Death - Suspected Cause - Side Effect Reports

 
 



Index of reports > Death (28)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Niaspan (Niacin Extended-Release) death. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Niaspan side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-03

Patient: female

Reactions: Breast Cancer, Metastatic Neoplasm

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan



Possible Niaspan side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-02

Patient: female

Reactions: Metastatic Neoplasm, Breast Cancer

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan



Possible Niaspan side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-03

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan



Possible Niaspan side effects in male

Reported by a consumer/non-health professional from United States on 2012-02-20

Patient: male

Reactions: Ischaemic Cardiomyopathy, Dyspnoea, Dementia, Hypophagia, Coronary Artery Occlusion, Renal Failure Chronic, Myocardial Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: High Density Lipoprotein Decreased
    End date: 2012-02-04

Niaspan
    Indication: LOW Density Lipoprotein Increased

Trilipix
    Indication: LOW Density Lipoprotein Increased

Trilipix
    Administration route: Oral
    Indication: High Density Lipoprotein Decreased
    End date: 2012-02-04

Other drugs received by patient: Spiriva; Unknown Nebulization Medication; Imdur; Haloperidol; Hydralazine HCL; Unknown Inhaler; Carvedilol; Citalopram Hydrobromide



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-17

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Dyslipidaemia
    Start date: 2007-12-10
    End date: 2008-03-09

Niaspan
    Indication: Arteriosclerosis

Other drugs received by patient: Simvastatin; Simvastatin; Diuretics; Aspirin; Beta-Blockers; ACE Inhibitors



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2006-10-09
    End date: 2007-05-14

Niaspan
    Indication: Dyslipidaemia

Other drugs received by patient: Plavix; Calcium Channel Blockers; Warfarin OR Heparin Analog; Thiazolidinediones; Simvastatin; Angiotensin II Receptor Blockers; Hormone Replacement Therapy; Simvastatin; Progesterone



Possible Niaspan side effects in male

Reported by a physician from Canada on 2012-01-16

Patient: male

Reactions: Pancreatitis Acute, Cardiac Failure, Bronchitis, Chronic Obstructive Pulmonary Disease, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Dyslipidaemia
    Start date: 2007-06-07
    End date: 2010-03-25

Niaspan
    Indication: Arteriosclerosis

Other drugs received by patient: Simvastatin; Diuretics; Calcium Channel Blockers; Nitrates; Angiotensin II Receptor Blockers; Simvastatin; Aspirin



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Dyslipidaemia
    Start date: 2008-05-15
    End date: 2010-01-08

Niaspan
    Indication: Arteriosclerosis

Other drugs received by patient: Diuretics; Aspirin; Plavix; Sulfona Urea; Simvastatin; Beta Blocking Agents; ACE Inhibitors; Calcium Channel Blockers; Simvastatin; Metformin HCL



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan

Niaspan
    Administration route: Oral
    Indication: Dyslipidaemia
    Start date: 2007-12-10
    End date: 2008-03-09

Other drugs received by patient: ACE Inhibitors; Simvastatin; Beta-Blockers; Simvastatin; Diuretics; Aspirin



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2006-10-18
    End date: 2010-06-25

Niaspan
    Indication: Dyslipidaemia

Other drugs received by patient: Aspirin; Beta Blocking Agents; Simvastatin; ACE Inhibitors; Plavix; Diuretics; Simvastatin



Possible Niaspan side effects in male

Reported by a physician from Canada on 2012-01-16

Patient: male

Reactions: Humerus Fracture, Neoplasm Malignant

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2009-05-26
    End date: 2009-10-10

Niaspan
    Indication: Dyslipidaemia

Other drugs received by patient: Simvastatin; Beta Blocking Agents; Aspirin; Simvastatin



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Renal Failure, Pneumonia, Respiratory Failure, Sepsis

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2006-02-16
    End date: 2010-02-07

Niaspan
    Indication: Dyslipidaemia

Other drugs received by patient: Beta Blocking Agents; Nitrates; Other Diabetes Treatments; Simvastatin; Aspirin; ACE Inhibitors; Simvastatin; Calcium Channel Blockers



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Dysphagia, Neoplasm Malignant

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Dyslipidaemia
    Start date: 2006-06-29
    End date: 2011-08-05

Niaspan
    Indication: Arteriosclerosis

Other drugs received by patient: Beta Blockers; Diuretics; Nsaids; ACE Inhibitors; Simvastatin; Simvastatin; Calcium Channel Blockers



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Haemorrhage

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Indication: Dyslipidaemia

Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2006-10-16
    End date: 2009-06-09

Other drugs received by patient: Simvastatin; Beta Blocking Agents; Simvastatin; Aspirin; ACE Inhibitors; Metformin HCL; Sulfona Urea



Possible Niaspan side effects in female

Reported by a physician from United States on 2012-01-16

Patient: female

Reactions: Lung Disorder, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Indication: Dyslipidaemia

Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2008-02-07
    End date: 2010-05-08

Other drugs received by patient: Diuretics; Beta-Blockers; ACE Inhibitors; Nsaid's; Plavix; Simvastatin; Aspirin; Simvastatin



Possible Niaspan side effects in female

Reported by a physician from United States on 2012-01-16

Patient: female

Reactions: Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2008-11-03
    End date: 2009-01-19

Niaspan
    Indication: Dyslipidaemia

Other drugs received by patient: ACE Inhibitors; Simvastatin; Beta-Blockers; Simvastatin; Aspirin



Possible Niaspan side effects in male

Reported by a physician from Canada on 2012-01-16

Patient: male

Reactions: Neoplasm Malignant

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Dyslipidaemia
    Start date: 2006-02-14
    End date: 2009-08-05

Niaspan
    Indication: Arteriosclerosis

Other drugs received by patient: Diuretics; Metformin HCL; Simvastatin; Aspirin; Simvastatin; Beta-Blockers; Angiotensin II Receptor Blockers; Plavix; Sulfona Urea; Calcium Channel Blockers



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Indication: Dyslipidaemia

Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2006-10-31
    End date: 2011-02-12

Other drugs received by patient: Simvastatin; Beta-Blockers; Digitalis Preparations; Nitrates; Aspirin; Nsaid's; Plavix; Simvastatin; ACE Inhibitors; Angiotensin II Recptor Blockers; Diuretics



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Respiratory Failure

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Indication: Dyslipidaemia

Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2008-10-15
    End date: 2011-02-06

Other drugs received by patient: Simvastatin; ACE Inhibitors; Calcium Channel Blockers; Aspirin; Sulfona Urea; Diuretics; Metformin HCL; Beta-Blockers; Simvastatin



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Sepsis, Myocardial Infarction

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2007-10-15
    End date: 2007-11-26

Niaspan
    Indication: Dyslipidaemia

Other drugs received by patient: Diuretics; Simvastatin; Aspirin; Plavix; Beta-Blockers; Simvastatin; Calcium Channel Blockers



Possible Niaspan side effects in female

Reported by a physician from United States on 2012-01-16

Patient: female

Reactions: Cerebral Artery Embolism, Septic Embolus

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Indication: Dyslipidaemia

Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2009-04-06
    End date: 2011-01-15

Other drugs received by patient: Simvastatin; Beta Blocking Agents; Plavix; Simvastatin; Corticosteroids; Nitrates; Aspirin



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Indication: Dyslipidaemia

Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2006-05-17
    End date: 2010-01-27

Other drugs received by patient: Simvastatin; Plavix; ACE Inhibitors; Nitrates; Aspirin; Simvastatin; Diuretics



Possible Niaspan side effects in male

Reported by a physician from Canada on 2012-01-16

Patient: male

Reactions: Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2006-10-05
    End date: 2010-04-12

Niaspan
    Indication: Dyslipidaemia

Other drugs received by patient: Simvastatin; Sulfona Urea; Beta-Blockers; ACE Inhibitors; Diuretics; Simvastatin; Aspirin; Corticosteroids



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Lung Disorder

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan
    Indication: Dyslipidaemia

Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2008-09-11
    End date: 2010-05-25

Other drugs received by patient: ACE Inhibitors; Diuretics; Simvastatin; Simvastatin; Aspirin; Warfarin OR Heparin Analog



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Depressed Level of Consciousness, Cerebrovascular Accident

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Indication: Dyslipidaemia

Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2008-11-25
    End date: 2010-05-07

Other drugs received by patient: Beta Blockers; Simvastatin; Aspirin; ACE Inhibitors; Simvastatin



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Neoplasm Malignant, Haemoptysis, Lung Neoplasm Malignant

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2007-10-16
    End date: 2008-05-20

Niaspan
    Indication: Dyslipidaemia

Other drugs received by patient: Simvastatin; Simvastatin; Aspirin; Beta-Blockers



Possible Niaspan side effects in male

Reported by a physician from United States on 2012-01-16

Patient: male

Reactions: Myocardial Infarction, Influenza

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan

Niaspan
    Administration route: Oral
    Indication: Arteriosclerosis
    Start date: 2006-08-21
    End date: 2009-12-30

Other drugs received by patient: Metformin HCL; Beta Blockers; Nitrates; Simvastatin; Plavix; Other Diabetic Treatments; Diuretics; Sulfona Urea; Digitalis Preparation; Aspirin; Angiotensionii Receptor Blockers; Simvastatin



Possible Niaspan side effects in male

Reported by a consumer/non-health professional from United States on 2011-10-05

Patient: male

Reactions: Hepatic Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Niaspan

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012